Delivery Order SPE2DB25D3012-SPE2DB25FXAFM
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for SKYRIZI 150 MG/ML in pen/milliliter format, with a contract ceiling value of $20,981.41. This firm fixed-price delivery order, awarded on September 3, 2025, with an ultimate completion date of September 4, 2025, represents a non-competitive set-aside contract. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. As a major...
- The Defense Logistics Agency awarded a delivery order valued at $55,373.90 to AmerisourceBergen Drug Corp for the supply of SKYRIZI 150 mg/ml in pen format. This is a firm fixed price, non-set-aside contract with an ultimate completion date of August 20, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor and critical federal vendor specializing in medical procurement for military and veteran healthcare systems. This delivery order falls...
- The Defense Logistics Agency (DLA) awarded a $45,053.85 firm fixed price delivery order to AmerisourceBergen Drug Corp for the supply of SKYRIZI 150 mg/ml syringes. This non-competitive delivery order, awarded on August 8, 2025, with an ultimate completion date of August 11, 2025, represents a small but specialized pharmaceutical procurement fulfilling federal medical supply requirements. The contract is being performed at AmerisourceBergen's corporate office location in Conshohocken,...
- The Defense Logistics Agency awarded a $63,561.98 delivery order to AmerisourceBergen Drug Corp for SKYRIZI 150 MG/ML pen/mL, a pharmaceutical product for federal medical supply needs. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and carries an ultimate completion date of June 13, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor for federal military and veteran healthcare...
- The Defense Logistics Agency awarded a delivery order valued at approximately $55,954.56 to AmerisourceBergen Drug Corp for the supply of SKYRIZI 150 MG/ML in pen/milliliter format. This is a firm fixed price, non-set-aside contract with a completion date of September 30, 2025, issued on September 29, 2025. The order will be fulfilled from AmerisourceBergen's operations in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $49,815.97 to AmerisourceBergen Drug Corp for SKYRIZI 150 mg/ml pen/ml pharmaceutical product. This firm fixed price delivery order, issued on September 26, 2025, with an ultimate completion date of September 29, 2025, was competitively awarded without set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor for federal...
- The Defense Logistics Agency awarded a $24,366.80 delivery order to AmerisourceBergen Drug Corp for SKYRIZI 150 mg/ml syringes, with an ultimate completion date of August 14, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and is classified as a child order under AmerisourceBergen's larger indefinite delivery contract vehicle with DLA Troop Support Medical. The product will be delivered to the company's facility in Conshohocken, Pennsylvania. This delivery...
- The Defense Logistics Agency awarded a delivery order valued at $36,795.40 to AmerisourceBergen Drug Corp for the supply of SKYRIZI 150 mg/mL pharmaceutical product. This firm fixed-price, competitively awarded delivery order was issued on August 26, 2025, with an ultimate completion date of August 27, 2025. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's existing Indefinite...
- The Defense Logistics Agency awarded a $36,158.91 delivery order to AmerisourceBergen Drug Corp on August 1, 2025, for the supply of SKYRIZI 150 mg/ml syringes. This is a firm fixed-price, non-set-aside contract with performance to be completed by August 4, 2025, at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, serves as a critical vendor for federal medical procurement, particularly...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a $40,663.63 firm fixed price delivery order to AmerisourceBergen Drug Corp for SKYRIZI 150 MG/ML syringes on August 25, 2025, with completion targeted for August 26, 2025. This non-competed delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) vehicle with DLA Troop Support Medical, valued at $999,999,999 and running through December 2026. The product will be delivered to...
- SPE2DB25D3012Indefinite Delivery Contract
- SPE2DB25D3012-SPE2DB25FXAFMDelivery Order
The Defense Logistics Agency (DLA) awarded a delivery order valued at $36,222.60 to AmerisourceBergen Drug Corp for SKYRIZI 150 mg/ml syringes, with an ultimate completion date of September 18, 2025. This is a firm fixed price, competitively awarded contract with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. As a major pharmaceutical distributor and healthcare solutions provider, AmerisourceBergen serves as a critical vendor for federal medical procurement, particularly supporting military and veteran healthcare systems through the DLA's Medical Supply Chain. This delivery order is issued under AmerisourceBergen's substantial Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. This prime contract vehicle enables the company to supply a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally, including specialty medications, brand-name and generic drugs, vaccines, and other critical medical commodities. The contract supports the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems, positioning AmerisourceBergen as a key provider within DLA's Pharmaceutical Prime Vendor Global Program.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $36.2k | 9/17/25 |